Effectiveness Monitoring of Home Non-invasive Mechanical Ventilation by Digital Diagnosis Platform
- Conditions
- Lung Disease, RestrictiveNeuromuscular DiseasesObesity Hypoventilation Syndrome
- Registration Number
- NCT03085537
- Lead Sponsor
- Corporacion Parc Tauli
- Brief Summary
The main objective will be to determine the effectiveness of home non-invasive ventilation by flow-time and time-pressure curves analysis in a cohort of patients with this treatment by digital diagnosis platform.
- Detailed Description
A multicenter study with observational prospective design will be implemented on 3 spanish hospitals in Barcelona. Inclusion criteria will be equivalent sample size of patients with restrictive lung disease, neuromuscular pathology and hypoventilation-obesity.
Digital diagnosis platform will be used to incorporate and unify signals of different medical devices: a pneumotachograph on branch ventilator that captures pressure and flow-time signals, inductance plethysmography used to like a patient effort sensor and portable pulse oximeter recordings. Nocturnal polygraphic or polysomnographic tracings performed and recorded on sites will be processed systematically by main asynchronies diagnosis algorithms between patient and ventilator. These algorithms providing global and fractionated asynchronies count based on time, leaks or saturation criteria which will be used to compared effective ventilation phases and phases with nocturnal desaturations. Therefore, prevalence and asynchronies model on home NIV can be determine establishing the correlation between desaturation phases and respiratory events and identifying minimum tolerable leak level to keep adequate ventilation.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 40
- Home non-invasive mechanical ventilation and clinical stability at least of 6 months ( no acute episode with admission on 2 months before)
- Mean Ventilator compliance > 4 h/ per night on screening visit
- Signed informed consent form previously
- Ventilation with oxygen join system.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Asynchronies Index One week after screening visit if the subject comply inclusion criteria. Asynchronies analysis will be performed once (cross-sectional design) by nocturnal polygraphy on site during one night Number of respiratory events registered automatically by digital diagnosis platform
- Secondary Outcome Measures
Name Time Method Demographics parameters- age screening visit age in years
Demographics parameters- sex screening visit sex: man or woman
PaCO2 screening visit PaCo2 measured by blood gas test (mmHg) \< 45
Pittsburgh Sleep Quality Index. (PSQI) screening visit questionaire of sleep quality with ventilation.
Mode Ventilator recorded date on screening visit pressure or volume controlled modes. select the option at ventilator setings
Interfaces recorded date on screening visit kind of mask using between the patient and ventilator. Total face mask, nasal mask, oro-nasal mask depend of patient characteristics
Tube recorded date on screening visit Kind of tuve, simple or doublé between patient and ventilator
Antyrebreathing system recorded date on screening visit Kind of system that avoid rebreathing CO2: acitve valve, leak controlled mask, leak controlled tube or double circuit
Leaks One week after screening visit if the subject comply inclusion criteria. leaks analysis will be performed once (cross-sectional design) by nocturnal polygraphy on site during one night Presence or not of intencionals and unintencionals leaks recorded
Oxygen saturation One week after screening visit if the subject comply inclusion criteria. Oxygen saturation analysis will be performed once by nocturnal polygraphy once (cross-sectional design) on site during one night Measure by pulsy oxymetry (%)
Pathology indication screening visit asociated with starting mechanical ventilation
Compliance ventilator recorded date on screening visit complying or not mínimum hours to recruiting (4h)
Trial Locations
- Locations (3)
Hospital universitari de Bellvitge
🇪🇸Hospitalet de Llobregat, Barcelona, Spain
Corporación Sanitaria Parc Tauli
🇪🇸Sabadell, Barcelona, Spain
Hospital Vall d´Hebron
🇪🇸Barcelona, Spain